{"id":900394,"date":"2025-10-27T10:13:08","date_gmt":"2025-10-27T14:13:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/"},"modified":"2025-10-27T10:13:08","modified_gmt":"2025-10-27T14:13:08","slug":"esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/","title":{"rendered":"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ANN ARBOR, Mich., Oct.  27, 2025  (GLOBE NEWSWIRE) &#8212; Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November 7-10, 2025.<\/p>\n<p>\n        <strong><br \/>\n          <u>Oral Presentation <\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Bempedoic acid monotherapy, LDL cholesterol, and cardiovascular events: a secondary analysis of the CLEAR Outcomes trial<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>November 9, 2025, 9:45 \u2013 11:00 AM CST<br \/>Presenter: Carolina Pires Zingano, MD (Cleveland Clinic)<\/p>\n<p>\n        <strong><br \/>\n          <u>Poster Presentation<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Effects of Bempedoic Acid on Venous Thromboembolism: a Post-Hoc Analysis of the CLEAR Outcomes trial<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Moderated Digital Poster Session, VM.MDP.07 Top Clinical and Translational Abstracts in Vascular Medicine:\u00a0<br \/>November 9, 2025, 11:50 AM \u2013 1:05 PM CST<br \/>Presenter: Bernardo Frison Spiazzi, MD (Cleveland Clinic)<\/p>\n<p>\u201cThe landmark CLEAR Outcomes trial continues to provide clinically meaningful insights that highlight the challenges of statin intolerance and reinforce the importance of expanding treatment options for patients at risk of cardiovascular events due to elevated LDL-C,\u201d said Sheldon Koenig, president and CEO of Esperion.<\/p>\n<p>\n        <strong>About Esperion Therapeutics<\/strong><br \/>\n        <br \/>Esperion Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on bringing new medicines to market that address unmet needs of patients and healthcare professionals. The Company developed and is commercializing the only U.S. Food and Drug Administration (FDA) approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease and are struggling with elevated low density lipoprotein cholesterol (LDL-C). These medications are supported by the nearly 14,000 patient CLEAR Cardiovascular Outcomes Trial. Esperion continues to build on its success with its next generation program which is focused on developing ATP citrate lyase inhibitors (ACLYi). New insights into the structure and function of ACLYi fully enables rational drug design and the opportunity to develop highly potent and specific inhibitors with allosteric mechanisms.<\/p>\n<p>Esperion continues to evolve into a leading global biopharmaceutical company through commercial execution, international partnerships and collaborations and advancement of its pre-clinical pipeline. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iI4Ipo1O03i1Xf_BNa_5yWA28wiMshkkaCMQ6Yz9Pp5V9OeLtlKzC3OZhkyn1v-y68obhzyxhQYIMvqMLBeXAA==\" rel=\"nofollow\" target=\"_blank\"><u>esperion.com<\/u><\/a> and follow Esperion on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ihx_JM5R382jxxck0G3VVoiivT6saBYiMDFts6HCxdm9MU4B4I6PvJA7CXhq6K_juYneEz2Ra3H9Ke2URMDu496nopczHtZ0NOmE4BQVv6zBSFaHjoksbzJ4xLP9bkBu\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Iy2Pwa8UWX4BOKN_0vbDfxjfHmjvFDqb1nC8fEH7DYiScsiNbpfbHQYl15sdmHVVOeINh4CVFa_p-p9ex4THUA==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>.<\/p>\n<p>\n        <strong>Esperion Contact Information:<\/strong><br \/>\n        <br \/>Investors: <br \/>Alina Venezia<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dx-zs2ZKGFXDJTZU7lWAZgpCui6Ek_eVOV5PplLkLCDVmnB6eQbeuIvSkDEE4FxXz_dd6RA21WQhIvQZs8Ma3RSiYR63BxHsvotAghicHLBY16dCwRgbHQ8zsHikuzcs\" rel=\"nofollow\" target=\"_blank\"><u>investorrelations@esperion.com<\/u><\/a><br \/>(734) 887-3903<\/p>\n<p>Media: <br \/>Tiffany Aldrich <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=znqK6kTxuNIc3Dh9eLBKyg7ZwSAypBCdWnhnCno8KFBNVkjlGjchPpf7BZvCnot9JXcsUGkA_R-8C8Qj9sMU4OOA0Z_pBX-JshxdhnEaAZVVv4mgitNmrYAP8kNnBBkI\" rel=\"nofollow\" target=\"_blank\"><u>corporateteam@esperion.com<\/u><\/a><br \/>(616) 443-8438<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTEyN2IyM2YtOWUwZS00MzRlLThlY2QtNjdkNDA1MDk1NGMxLTEwMTg3MTQtMjAyNS0xMC0yNy1lbg==\/tiny\/Esperion-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) &#8212; Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November 7-10, 2025. Oral Presentation Bempedoic acid monotherapy, LDL cholesterol, and cardiovascular events: a secondary analysis of the CLEAR Outcomes trial November 9, 2025, 9:45 \u2013 11:00 AM CSTPresenter: Carolina Pires Zingano, MD (Cleveland Clinic) Poster Presentation Effects of Bempedoic Acid on Venous Thromboembolism: a Post-Hoc Analysis of the CLEAR Outcomes trial Moderated Digital Poster Session, VM.MDP.07 Top Clinical and Translational Abstracts in Vascular Medicine:\u00a0November 9, 2025, 11:50 AM \u2013 1:05 PM CSTPresenter: Bernardo Frison Spiazzi, MD (Cleveland Clinic) \u201cThe landmark CLEAR Outcomes &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-900394","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) &#8212; Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November 7-10, 2025. Oral Presentation Bempedoic acid monotherapy, LDL cholesterol, and cardiovascular events: a secondary analysis of the CLEAR Outcomes trial November 9, 2025, 9:45 \u2013 11:00 AM CSTPresenter: Carolina Pires Zingano, MD (Cleveland Clinic) Poster Presentation Effects of Bempedoic Acid on Venous Thromboembolism: a Post-Hoc Analysis of the CLEAR Outcomes trial Moderated Digital Poster Session, VM.MDP.07 Top Clinical and Translational Abstracts in Vascular Medicine:\u00a0November 9, 2025, 11:50 AM \u2013 1:05 PM CSTPresenter: Bernardo Frison Spiazzi, MD (Cleveland Clinic) \u201cThe landmark CLEAR Outcomes &hellip; Continue reading &quot;Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-27T14:13:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025\",\"datePublished\":\"2025-10-27T14:13:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/\"},\"wordCount\":348,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/\",\"name\":\"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=\",\"datePublished\":\"2025-10-27T14:13:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/","og_locale":"en_US","og_type":"article","og_title":"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025 - Market Newsdesk","og_description":"ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) &#8212; Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November 7-10, 2025. Oral Presentation Bempedoic acid monotherapy, LDL cholesterol, and cardiovascular events: a secondary analysis of the CLEAR Outcomes trial November 9, 2025, 9:45 \u2013 11:00 AM CSTPresenter: Carolina Pires Zingano, MD (Cleveland Clinic) Poster Presentation Effects of Bempedoic Acid on Venous Thromboembolism: a Post-Hoc Analysis of the CLEAR Outcomes trial Moderated Digital Poster Session, VM.MDP.07 Top Clinical and Translational Abstracts in Vascular Medicine:\u00a0November 9, 2025, 11:50 AM \u2013 1:05 PM CSTPresenter: Bernardo Frison Spiazzi, MD (Cleveland Clinic) \u201cThe landmark CLEAR Outcomes &hellip; Continue reading \"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-27T14:13:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025","datePublished":"2025-10-27T14:13:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/"},"wordCount":348,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/","name":"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=","datePublished":"2025-10-27T14:13:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0NTQ5MiM3MTk1NTQyIzIwMDcxNDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-announces-new-analyses-from-clear-outcomes-to-be-presented-at-the-american-heart-association-aha-scientific-sessions-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/900394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=900394"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/900394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=900394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=900394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=900394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}